Document:

Securities Purchase Agreement

 Exhibit 10.1 
 SECURITIES PURCHASE AGREEMENT 
 THIS SECURITIES
PURCHASE AGREEMENT (this “Agreement”) is made as of October 17, 2006, by and between QUEPASA CORPORATION, a Nevada
corporation (the “Company”), and MEXICANS & AMERICANS TRADING TOGETHER, INC., a Delaware corporation (the
“Investor”). 
 WHEREAS, the Company desires to sell to the Investor, and the Investor desires to purchase
from the Company, 1,000,000 shares (the “Common Shares”) of the common stock, par value $0.001, of the Company (“Common Stock”) upon the terms and subject to the conditions set forth herein;

 WHEREAS, in connection with the foregoing, the Company desires to issue to the Investor, and the Investor desires to receive
(i) a warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $12.50 per share (subject to adjustment), in the form attached hereto as Exhibit A (the “Series 1 Warrant”), and (ii) a
warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $15.00 per share (subject to adjustment), in the form attached hereto as Exhibit B (the “Series 2 Warrant” and, together with the Series 1
Warrant, the “Warrants” and the shares issuable upon exercise of the Warrants, the “Warrant Shares”); 
 WHEREAS, to facilitate the transaction, the Company has agreed (i) to make certain representations, warranties and covenants herein, (ii) to register for resale the Common Shares and Warrant Shares in
accordance with that certain Registration Rights Agreement made by and between the Company and the Investor, in the form attached hereto as Exhibit C (the “Registration Rights Agreement”), and (iii) to enter into
a Support Agreement with Investor in the Form of Exhibit E hereto (the “Support Agreement” and, together with this Agreement, the Warrants, and the Registration Rights Agreement, the “Transaction
Documents”); 
 NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement and for other good
and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows: 
 ARTICLE I. 
 PURCHASE AND SALE; CLOSING 
 1.1 Purchase and Sale of Common Shares; Issuance of Warrants. 
 (a) The Company
hereby sells to the Investor, and the Investor hereby purchases from the Company, the Common Shares on the terms set forth in this Agreement for a price of $10.00 per share, or an aggregate of $10,000,000 (the “Purchase
Price”). 
 (b) The Company hereby executes and delivers to the Investor, and the Investor hereby accepts, the Series 1
Warrant and the Series 2 Warrant. 
 1.2 Closing. The closing of the purchase of the Common Shares and the execution and
delivery of the Warrants (the “Closing”) shall occur at the offices of Snell & Wilmer L.L.P., at 10:00 a.m. (Los Angeles time) on the date hereof or such other time and location as the parties hereto shall mutually
agree (the date upon which the Closing occurs, the “Closing Date”). 

 (a) At the Closing, the Company shall deliver or cause to be delivered to the Investor the
following: 
 (i) a certificate evidencing the Common Shares being issued by the Company to the Investor hereunder, registered in the
name of the Investor; 
 (ii) the Series 1 Warrant being delivered by the Company to the Investor hereunder, registered in the name
of the Investor; 
 (iii) the Series 2 Warrant being delivered by the Company to the Investor hereunder, registered in the name of
the Investor; 
 (iv) an executed copy of the Registration Rights Agreement; 
 (v) an executed copy of the Support Agreement; and 
 (vi) an opinion of counsel to the Company in the form of Exhibit D hereto. 
 (b) At the
Closing, the Investor shall deliver or cause to be delivered to the Company the following: 
 (i) the Purchase Price, by wire transfer
of immediately available funds, to an account designated by the Company to the Investor in writing; 
 (ii) an executed copy of the
Registration Rights Agreement; and 
 (iii) an executed copy of the Support Agreement. 
 ARTICLE II. 
 REPRESENTATIONS AND
WARRANTIES 
 2.1 Representations and Warranties of the Company. The Company hereby makes the following
representations and warranties to the Investor (and any permitted assignees) as of the date hereof (all references to the Company in this Section 2.1, except for paragraphs (a) and (b), shall mean the Company and its subsidiaries):

 (a) Organization. The Company is duly organized, validly existing and in good standing under the laws of the State of Nevada,
with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. 
 (b) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to conduct its business as
currently conducted or proposed to be conducted, and to carry out its obligations thereunder. The execution and delivery of each 
  

 2 

 of the Transaction Documents by the Company and the consummation by it of the transactions contemplated thereby have been
duly authorized by all necessary action on the part of the Company and no further action is required by the Company in connection therewith. Each of the Transaction Documents has been duly executed and delivered by the Company and constitutes a
valid and binding obligation of the Company enforceable against it in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies (collectively (i) and (ii), the “Enforceability
Exceptions”). The Common Shares and each of the Warrants have been duly authorized by all necessary corporate action, and when issued, delivered and paid for in accordance with the terms of this Agreement, will be validly issued, fully
paid and nonassessable, and free and clear of all liens, claims, encumbrances, preemptive rights or restrictions on transfer (“Liens”) (other than those imposed under the Securities Act (as defined below)). The Warrant Shares
have been duly authorized by all necessary corporate action, and when issued, delivered and paid for in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, and free and clear of all Liens (other than
those imposed under the Securities Act). 
 (c) No Conflicts. The execution, delivery and performance of the Transaction
Documents by the Company and the consummation by the Company of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s certificate or articles of incorporation, bylaws or other
organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or
cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected,
or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority (collectively, “Legal Requirements”) to which the Company is
subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected. 
 (d) No Consents. No consent, approval, authorization or order of, or any filing by the Company or declaration with, any court or governmental agency or body or other person or entity (collectively, a
“Person”) is required in connection with the execution and delivery by the Company of the Transaction Documents and the consummation by the Company of the transactions contemplated thereby, except (i) the filing by the
Company with, and the declaration of effectiveness by, the Securities and Exchange Commission (the “Commission”) of one or more registration statements in accordance with the requirements of the Registration Rights Agreement,
(ii) the filing by the Company with the Commission of a current report on Form 8-K under the Exchange Act, and (iii) those consents, approvals, authorizations, orders, filings, or declarations that have been made or obtained prior to the
date of this Agreement. 
 (e) No Stockholder Approval; Antitakeover Provisions. No consent, approval, or authorization by the
Company’s stockholders is required, under any law, rule, or regulation to which the Company is subject, in connection with the execution and delivery by the Company of the Transaction Documents, and the consummation by the Company of the

  

 3 

 transactions contemplated thereby. No “poison pill,” control share statute, other state anti-takeover Legal
Requirement, or similar Legal Requirement or restriction on ownership or voting by the Investor of the Common Shares or the Warrant Shares will be triggered as a result of the consummation of the transactions contemplated by this Agreement. The
Company is not an “issuing corporation” within the meaning of Nevada Revised Statutes Sections 78.378 to 78.3793, because either the Company does not have 100 stockholders of record with Nevada addresses on its stock ledger or because it
does not do business in the State of Nevada. The Company is not an “issuing public corporation” under the Arizona Revised Statutes Sections 10-2701 to 10-2743 because is has fewer than 500 employees residing in the State of Arizona.

 (f) SEC Reports. Except as set forth on Schedule 2.1(f) hereto, the Company has filed all reports required to be
filed by it under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including pursuant to Section 13(a) or Section 15(d) thereof, and the rules and regulations of the Commission promulgated
thereunder, since January 1, 2003 (the foregoing reports and any materials incorporated therein by reference being collectively referred to herein as the “SEC Reports”) on a timely basis, or has received a valid
extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act of 1933,
as amended (the “Securities Act”), and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
 (g) Financial Statements. The financial statements filed with the Commission as a part of the SEC Reports present fairly, in all material
respects, the financial position of the Company and its subsidiaries on a consolidated basis as of and at the dates indicated and the results of their consolidated operations and cash flows for the periods specified therein, subject, in the case of
interim financial statements, to normal year-end adjustments which are not expected to be material in amount. Such financial statements have been prepared in conformity with generally accepted accounting principles as applied in the United States
and in effect as of the date of the applicable financial statements and supporting schedules, as applicable, applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto, and comply in
all material respects with the Securities Act, the Exchange Act and the applicable rules and regulations of the Commission thereunder. 
 (h) Listing. The Common Stock is registered under the Exchange Act and is listed on the National Association of Securities Dealers, Inc.’s Over-the-Counter Bulletin Board (the “NASD-BB”). The
Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock on the NASD-BB, nor has the Company received
any information suggesting that the Commission or the National Association of Securities Dealers, Inc. is contemplating terminating or suspending such registration or listing. 
  

 4 

 (i) Investment Company. The Company is not, and is not an affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended. 
 (j) Patents and Trademarks. The Company
has legal right, title, and interest or valid and enforceable licenses in and to all patent, copyright, trade secret, trademark or other proprietary rights (“Intellectual Property”) that it uses to conduct its business. To
its knowledge, the conduct of the Company’s business and use of its Intellectual Property does not infringe or otherwise conflict with any rights of any Person in respect of any Intellectual Property, and, to its knowledge, none of the
Intellectual Property owned by the Company is being infringed upon by any other Person. There is no claim, suit, action or proceeding pending or, to the knowledge of the Company, threatened against the Company: (i) alleging any such conflict or
infringement with any third party’s proprietary rights; or (ii) challenging the Company’s ownership or use of, or the validity or enforceability of any Intellectual Property. 
 (k) Compliance. The Company is in compliance, in all material respects, with all Legal Requirements, including the requirements of the
Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations thereunder, that are applicable to it. The Company is not in default or violation (and no event has occurred which with notice or the lapse of time or both would constitute a
default or violation) of any term, condition or provision of (a) its Charter or By-Laws, or (b) any material note, bond, mortgage, indenture, license, agreement, contract, lease, commitment or other obligation to which the Company is a
party or by which they or any of their properties or assets may be bound. 
 (l) Certain Registration Matters. In connection
with the offer of shares of Common Stock to the Investor, neither the Company nor anyone acting on its behalf has offered or will offer shares of Common Stock for issue or sale to, or solicited or will solicit any offer to acquire any of the same
from, anyone so as to require the issuance and sale of the shares of Common Stock to Investor or the issuance of shares upon exercise of the Warrants to be registered under Section 5 of the Securities Act. Assuming the accuracy of the
Investor’s representations and warranties set forth in Sections 2.2(c)-(f), no registration under the Securities Act is required in connection with the issuance and sale to the Investor of the Common Shares and Warrants or, upon exercise
thereof, the Warrant Shares, contemplated hereby. 
 (m) Capitalization. The number of shares and type of all authorized,
issued and outstanding capital stock of the Company, and all shares of Common Stock reserved for issuance under the Company’s option and incentive plans, warrants and preferred stock is set forth on Schedule 2.1(m) hereto. Except for the
warrants and stock option listed on Schedule 2.1 (m), which schedule lists the number of shares issuable upon the exercise of such warrants and stock options and the exercise price and the expiration date of such warrants and stock options,
on the Closing Date there will be no shares of Common Stock or any other equity security of the Company issuable upon conversion or exchange of any security of the Company convertible into or exchangeable for shares of capital stock of the Company,
nor will there be any rights, options or warrants outstanding or other agreements to acquire shares of Common Stock nor will the Company be contractually obligated to purchase, redeem or otherwise acquire any of its outstanding shares. Except as
described in Schedule 2.1(m), no stockholder of the Company is entitled to any preemptive or similar rights to subscribe for shares of capital stock of the 
  

 5 

 Company. No Person has any preemptive right, or any right of first refusal, right of participation, or any similar right
to participate in the transactions contemplated by this Agreement. There are no anti-dilution or price adjustment provisions contained in any security issued by the Company, or in any agreement to which the Company is a party and which provides
rights to security holders, that will be triggered by the transactions contemplated by this Agreement. 
 (n) Absence of Undisclosed
Liabilities. Except as reflected in the Company’s balance sheet as of June 30, 2006 included in the SEC Reports, the Company does not have any debt or material obligation or liability (whether accrued, absolute, contingent,
liquidated or otherwise, whether due or to become due), except: (i) taxes not yet due and payable, (ii) except current liabilities incurred and obligations under agreements entered into, in the ordinary course of business consistent with
past practice, (iii) contingent liabilities specifically referenced in the notes to such balance sheet, and (iv) as set forth on Schedule 2.1(n). 
 (o) Tax Matters. There are no U.S., Mexican, or other federal, state, county or local taxes due and payable by the Company which have not been paid. The provisions for taxes in the Financial Statements
are sufficient for the payment of all accrued and unpaid U.S., Mexican or other federal, state, county and local taxes of the Company whether or not assessed or disputed as of the respective dates of such Financial Statements. The Company has duly
filed all U.S., Mexican and other federal, state, county and local tax returns required to have been filed by it as of the date hereof and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.

 (p) Insurance. Subject to the receipt of the coverage listed on Schedule 2.1(p), the Company and its properties are insured
in such amounts, against such losses and with such insurers as are prudent when considered in light of the nature of the properties and businesses of the Company. No written notice of any termination or threatened termination of any of policies for
insurance has been received and such policies are in full force and effect. 
 (q) Litigation. No actions (including, without
limitation, derivative actions), suits, proceedings or investigations are pending or, to the knowledge of Company, threatened against Company at law or in equity in any court or before any other governmental authority which (i) if adversely
determined would (alone or in the aggregate) have a material adverse effect on the Company’s business operations and/or financial condition or (ii) seeks to enjoin, either directly or indirectly, the execution, delivery or performance by
Company of the Transaction Documents or the transactions contemplated thereby. 
 2.2 Representations and Warranties of the
Investor. The Investor hereby makes the following representations and warranties to the Company as of the date hereof. 
 (a)
Organization. The Investor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite power and authority to own and use its properties and assets and to carry on its
business as currently conducted. 
  

 6 

 (b) Authorization; Enforcement. The Investor has the requisite power and authority to enter
into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations thereunder. The execution and delivery by the Investor of each of the Transaction Documents to which it is a party and the
performance by the Investor of the transactions contemplated thereby have been duly authorized by all necessary action on the part of the Investor. Each of the Transaction Documents has been duly executed by the Investor, and constitutes a valid and
binding obligation of the Investor, enforceable against it in accordance with its terms, except for any Enforceability Exceptions. 
 (c)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Investor and the consummation by the Investor of the transactions contemplated thereby do not and will not (i) conflict with or violate any
provision of the Investor’s certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument or other understanding to which the
Investor is a party or by which any property or asset of the Investor is bound or affected, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Investor is subject (including federal and state securities laws and regulations), or by which any property or asset of the Investor is bound or affected; except in the case of each of clauses (ii) and (iii), such as
would not have or reasonably be expected to result in a material adverse effect on (A) the legality, validity or enforceability of the Transaction Documents, or (B) the Investor’s ability to perform in any material respect on a timely
basis its obligations under the Transaction Documents 
 (d) Investment Intent. The Investor understands that the Common
Shares, the Warrants, and the Warrant Shares are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law. The Investor is acquiring the Common Shares, Warrants and, upon exercise
thereof, the Warrant Shares as principal for its own account for investment purposes only and not with a view to or for distributing or reselling such Common Shares, Warrants or Warrant Shares or any part thereof, has no present intention of
distributing any of such Common Shares, Warrants or Warrant Shares and has no arrangement, agreement, or understanding (directly or indirectly) with any other Person regarding the distribution of any such Common Shares, Warrants or Warrant Shares
(provided, however, that this representation and warranty shall not in any way limit the Investor’s right to sell the Common Shares, Warrants or Warrants Shares pursuant to any registration statement or otherwise in compliance with applicable
federal and state securities laws). 
 (e) Investor Status. At the time the Investor was offered the Common Shares, Warrants
and Warrant Shares it was, and at the date hereof it is, an “accredited investor,” as such term is defined under the Securities Act. The Investor is not a registered broker-dealer under Section 15 of the Exchange Act. 
 (f) Experience of the Investor. The Investor, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters as to be capable of evaluating the merits and risks of the prospective investment in the 
  

 7 

 Common Shares, Warrants and, upon exercise thereof, the Warrant Shares and has evaluated the merits and risks of such
investment. The Investor is able to bear the economic risk of an investment in the Common Shares, Warrants and, upon exercise thereof, the Warrant Shares and is able to afford a complete loss of such investment. 
 (g) No General Solicitation. The Investor is not purchasing the Common Shares, Warrants and, upon exercise thereof, the Warrant Shares as a
result of any advertisement, article, notice or other communication published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or through any other general solicitation or general
advertisement. 
 (h) Access to Information. The Investor acknowledges that it has reviewed the SEC Reports and has been
afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Common Shares, Warrants and Warrant Shares
and the merits and risks of investing therein; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.

 (i) Certain Trading Activities. The Investor has not directly or indirectly engaged in any transactions in the securities of
the Company (including, without limitations, any short sales involving the Company’s securities) since the earlier to occur of (i) the time that the Investor was first contacted by the Company regarding an investment in the Company, and
(ii) the 30th calendar day prior to the date of this Agreement. The Investor covenants that it will not
directly or indirectly engage in any transactions in the securities of the Company (including short sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed. The Investor does not, directly or indirectly,
hold a short position in any shares of Common Stock. 
 ARTICLE III. 
 OTHER AGREEMENTS OF THE PARTIES 
 3.1 Transfer
Restrictions. 
 (a) The Common Shares, the Warrants, and, upon exercise thereof, the Warrant Shares may only be disposed of in
compliance with state and federal securities laws. In connection with any transfer of Common Shares, Warrants or Warrant Shares other than pursuant to an effective registration statement, to the Company, or to an affiliate (as defined under the
federal securities laws) of the Investor, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the
Company, to the effect that such transfer does not require registration of such transferred securities under the Securities Act. As a condition of transfer as a result of which the transferee will hold “restricted securities” within the
meaning of Rule 144, any such transferee shall agree in writing to be bound by Section 3.1 of this Agreement and shall have the rights of the Investor under the Registration Rights Agreement. 
  

 8 

 (b) Investor understands that so long as is required by this Section 3.1, a legend
shall be placed on the Common Shares, the Warrants and, upon exercise thereof, the Warrant Shares in substantially the following form: 
 THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR
THESE SHARES UNDER THE SECURITIES ACT OF 1933 OR IN A TRANSACTION WHICH IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY IS EXEMPT FROM SUCH REGISTRATION REQUIREMENT. 
 (c) Certificates evidencing the Common Shares, Warrants and Warrant Shares shall not contain the legend set forth in Section 3.1(b),
(i) following any sale of such securities pursuant to Rule 144, unless otherwise required by applicable law, (ii) if such securities are eligible for sale under Rule 144(k), or (iii) if such legend is not required under applicable
requirements of the Securities Act, and, in each case, upon the request of the Investor, the Company shall cause its counsel to issue a legal opinion to its transfer agent to effect the removal of the legend hereunder. The Company agrees that at
such time as the legend is no longer required under this Section 3.1(c), it will, promptly following the delivery by the Investor to the Company’s transfer agent of a certificate representing shares of Common Stock issued with a
restrictive legend (and such documents as the Company or the transfer agent may reasonably request), deliver or cause to be delivered to the Investor a certificate representing such shares that is free from the legend set forth in
Section 3.1(b). 
 3.2 Press Release. As soon as practicable on the Closing Date, the Company shall issue a
press release reasonably acceptable to the Investor disclosing the transactions contemplated hereby. Until the press release has been issued, the Investor acknowledges and agrees that this transaction constitutes confidential information pertaining
to the Company, and that it may not use or disclose such information until released by the Company. 
 3.3 Board
Representative. Promptly following the Closing, the Company will take all appropriate action to effect the appointment of one person designated by Investor (the “Investor Designee”) to its Board of Directors;
provided, that, as a condition to such appointment, such designee must first be considered by, and receive the affirmative approval of, the Company’s nominating and corporate governance committee. Mr. Alonso Ancira has already received
such approval. So long as the Investor and its affiliates beneficially own (within the meaning of the Exchange Act) at least 5% of the Common Stock, the Company shall nominate for election at each meeting of its stockholders at which an election of
directors shall be held one Investor Designee. In addition, during such time as the Investor and its Affiliates beneficially own (within the meaning of the Exchange Act) at least 20% of the Common Stock (without giving effect to any outstanding
warrants (including the Warrants), options or similar rights 
  

 9 

 held by any party), the Company shall, at the written request of the Investor and in addition to the Investor Designee,
nominate for election at each meeting of its stockholders at which an election of directors shall be held an additional director designated by the Investor who shall be “independent” of the Company within the meaning of the rules of the
New York Stock Exchange (or any other exchange on which the Company’s Common Stock is listed or admitted for trading) (the “Independent Designee”); provided, that, as a condition to such nomination, any such Independent
Designee must first be considered by, and receive the affirmative approval of, the Company’s nominating and corporate governance committee. If either the Investor Designee or, if applicable, the Independent Designee does not receive the
requisite vote of stockholders of the Company for election to its Board of Directors, the Company, at the written request of the Investor, shall appoint a different Investor Designee or, if applicable, Independent Designee to fill the vacancy on the
Board of Directors caused by the failure to elect the original Investor Designee or Independent Designee, as applicable; provided, that, as a condition to such appointment, any such different Investor Designee or, if applicable, Independent Designee
must first be considered by, and receive the affirmative approval of, the Company’s nominating and corporate governance committee; provided, however, that this sentence shall not apply in the circumstance where in lieu of the Investor Designee
or the Independent Designee there was elected a candidate who was neither nominated, endorsed nor supported by the Company’s Board of Directors or management. The Company shall not form any executive or similar committee of its Board of
Directors which has the effect of excluding the Investor Designee from active participation on matters requiring approval of the Board of Directors. During such time as an Investor Designee serves on the Board of Directors, except with the consent
of the Investor (which may be withheld in its sole and absolute discretion) the Company shall maintain commercially reasonable Directors and Officers Insurance. The Investor Designee shall be express third party beneficiaries of this sentence and
the preceding sentence. 
 3.4 Most Favored Nation’s Provision. To the extent that the Company or any of its subsidiaries extends
any corporate governance rights, stockholder rights or similar rights (including, the right to designate nominees for service on the Board of Directors, preemptive rights, protection against dilutive events, registration rights or the right to
participate in any offering by the Company) to Richard L. Scott, F. Stephen Allen or any of their respective Affiliates (as defined in the Securities Act), successors or assigns, then the Company shall extend the same rights to the Investor. This
Section 3.4 shall be solely for the purpose of expanding the Investor’s rights under the Transaction Documents and in no way shall this Section limit the Investor’s rights under the Transaction Documents. 
 ARTICLE IV. 
 MISCELLANEOUS

 4.1 Fees and Expenses. At Closing, the Company shall reimburse Investor for the fees and expenses of its counsel,
not to exceed $35,000. Except as otherwise set forth in this Agreement or any other agreement between the parties, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company and the Investor acknowledge that each has been represented by its own separate legal counsel in its review and
negotiation of the Transaction Documents. 
  

 10 

 4.2 Governing Law. This Agreement shall be governed by, and construed and enforced
in accordance with, the laws of the State of Nevada, without giving effect to conflict of laws or any other rules or principles which may require the application of the laws of any other jurisdiction. 
 4.3 Entire Agreement. This Agreement, together with the exhibits and schedules hereto, the Warrants, the Registration Rights
Agreement and the Support Agreement, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules. 
 4.4 Binding Effect. All of the terms,
provisions and conditions hereof shall be binding upon and shall inure to the benefit of and be enforceable by the parties hereto, and their respective heirs, personal representatives, successors and assigns. 
 4.5 Headings; Construction. The headings contained herein are for the purposes of convenience only, and will not be deemed to
constitute a part of this Agreement or to affect the meaning or interpretation of this Agreement in any way. Unless the context clearly states otherwise, the use of the singular or plural in this Agreement shall include the other and the use of any
gender shall include all others. The parties have participated jointly in the negotiation and drafting of this Agreement. If any ambiguity or question of intent or interpretation arises, no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. All references herein to Sections shall refer to this Agreement unless the context clearly otherwise requires. 
 4.6 Notices. All notices and other communications hereunder shall be in writing and shall be deemed given upon
(a) transmitter’s confirmation of receipt of a facsimile transmission, if during normal business hours of a business day, otherwise on the next business day, (b) confirmed delivery by a standard overnight carrier or when delivered by
hand or (c) the expiration of five (5) business days (or seven (7) business days where the addressee is not in the United States) after the day when mailed by certified or registered mail, postage prepaid, to the addresses set forth
in on the signature pages hereto or to such other address as any party may, from time to time, designate in a written notice given in a like manner. 
 4.7 Severability of Provisions. If a court in any proceeding holds any provision of this Agreement or its application to any Person or circumstance invalid, illegal or unenforceable, the remainder
of this Agreement, or the application of such provision to persons or circumstances other than those to which it was held to be invalid, illegal or unenforceable, shall not be affected, and shall be valid, legal and enforceable to the fullest extent
permitted by law, but only if and to the extent such enforcement would not materially and adversely frustrate the parties’ essential objectives as expressed in this Agreement. Furthermore, in lieu of any such invalid or unenforceable term or
provision, the parties intend that the court add to this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be valid and enforceable, so as to effect the original intent of the parties to the greatest extent
possible. 
  

 11 

 4.8 Third Party Beneficiaries. Except as set forth in Section 3.3, this
Agreement does not create, and will not be construed as creating, any rights enforceable by any Person not a party to this Agreement. 
 4.9 Amendment. This Agreement may be amended, modified, superseded, or canceled only by a written instrument signed by all of the parties hereto and any of the terms, provisions and conditions hereof may be waived, only
by a written instrument signed by the waiving party. 
 4.10 Counterparts; Facsimile Signatures. This Agreement may be
executed in any number of counterparts and each such counterpart shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Facsimile signatures on this Agreement shall be
deemed to be original signatures for all purposes. 
 4.11 Survival. The representations, warranties, covenants and
agreements contained herein shall survive the purchase and sale of the Common Shares and the Warrant Shares. 
 [Signatures on following
page] 
  

 12 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above. 
  

			
	 QUEPASA CORPORATION
 7550 E. Redfield
Road, Suite A
 Scottsdale, AZ 85260

	Fax:	 	  

	Attn:	 	Robert B. Stearns
		
	By:	 	 /s/ Robert B. Stearns

	Name:	 	Robert B. Stearns
	Title:	 	Chairman and Chief Executive Officer
	
	 MEXICANS & AMERICANS TRADING
 TOGETHER, INC.

	7550 IH 10 West, Suite 630
	San Antonio, TX 78229
	Fax:	 	  

	Attn:	 	Andres Gonzalez Saravia
		
	By:	 	 /s/ Andres Gonzalez Saravia

	Name:	 	Andres Gonzalez Saravia
	Title:	 	President

 Exhibit A 
 Form of Series 1 Warrant 

 Exhibit B 
 Form of Series 2 Warrant 

 Exhibit C 
 Form of Registration Rights Agreement 

 Exhibit D 
 Form of Opinion of Company Counsel 

 Exhibit E 
 Form of Support AgreementSeries 1 Common Stock Purchase Warrant

 Exhibit 10.2 
 QUEPASA CORPORATION 
 Common Stock Purchase Warrant 
 (Series 1) 

			
	 Warrant No.: MATT No. 1
	  	1,000,000 Shares of Common Stock

 Issued as of October 17, 2006 (the “Issue Date”)

 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES OR BLUE SKY LAWS OF ANY STATE, AND NEITHER THIS WARRANT NOR SUCH SHARES OF COMMON STOCK MAY BE SOLD, ENCUMBERED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT, OR AN EXEMPTION THEREFROM, AND, IF AN EXEMPTION SHALL BE APPLICABLE, THE HOLDER SHALL HAVE DELIVERED AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE COMPANY THAT SUCH EXEMPTION APPLIES AND THAT REGISTRATION IS
NOT REQUIRED UNDER THE SECURITIES ACT. 
 Expires and is void after 5:00 p.m. E.S.T. 
 October 17, 2016 (the “Expiration Date”). 
 Warrant for the Purchase of Common Stock, Par Value $.001 Per Share 
 QUEPASA
CORPORATION 
 FOR VALUE RECEIVED, QUEPASA CORPORATION, a Nevada corporation with its offices at 7550 E. Redfield Road, Suite A,
Scottsdale, AZ 85260 (the “Company”), hereby certifies that MEXICANS & AMERICANS TRADING TOGETHER, INC. a Delaware corporation, or its assigns (the “Holder”), is entitled to purchase upon
exercise of this warrant (the “Warrant”), subject to the provisions hereof, from the Company, at a price per share set forth in the Section 1 hereof (the “Exercise Price”), the number of
fully paid and non-assessable shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) set forth above (the “Warrant Shares”), subject to adjustment as provided in
Section 8 hereof. Capitalized terms used herein but not defined shall have the meanings assigned them in that certain Securities Purchase Agreement, dated as of the date hereof, by and between the Company and Holder (the
“Securities Purchase Agreement”). 
 1. EXERCISE PRICE. The Exercise Price for any shares of Common Stock purchased
upon exercise of this Warrant shall be $12.50 per share, subject to adjustment as provided herein. 
 2. EXERCISE OF WARRANT. Subject to the
terms and conditions set forth herein, this Series 1 Warrant shall be exercisable (in whole or in part) during the term commencing on the 

 Issue Date hereof and ending at 5:00 p.m., Eastern Standard Time, on the Expiration Date set forth above (the
“Exercise Period”). At any time during the Exercise Period, this Warrant shall be exercisable (in whole or in part) by presentation and surrender hereof to the Company at its principal office at the address set forth in the
initial paragraph hereof (or at such other address as the Company may hereafter notify Holder of in writing), with the Purchase Form annexed hereto duly executed and accompanied by proper payment of the applicable Exercise Price in lawful money of
the United States of America in the form of cash or its equivalent, subject to adjustment as set forth herein, or any lesser number set forth in the Purchase Form. Upon receipt by the Company of this Warrant at its principal office, in proper form
for exercise, Holder shall be deemed to be the holder of record of the shares of Common Stock issuable upon such exercise, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such
shares of Common Stock shall not be actually delivered to Holder at the time of such exercise. 
 3. ISSUANCE OF CERTIFICATE FOR WARRANT
SHARES. Subject to Section 3.1 of the Securities Purchase Agreement and Section 10 of this Warrant, as soon as practicable after the exercise of this Warrant, and in any event within ten
(10) days following such exercise, the Company at its expense will cause to be issued in the name of, and delivered to, Holder a certificate or certificates for the number of full shares of Common Stock to which such Holder shall be entitled
upon such exercise. Additionally, upon delivery of the certificate to Holder, the Company shall, in lieu of any fractional shares of Common Stock to which Holder would have otherwise herein been entitled upon the exercise of this Warrant, pay to
Holder cash in an amount to be determined by and in accordance with Section 5 hereof. If Holder chooses to exercise this Warrant in part, then, in addition to delivering to Holder a certificate or certificates for the number of full
Warrant Shares to which such Holder shall be entitled upon such exercise, the Company shall also deliver to Holder a new Warrant of like tenor and date exercisable for the remaining number of Warrant Shares. 
 4. SHARES FULLY PAID; RESERVATION OF SHARES. The Company represents to Holder that all Warrant Shares that may be issued upon the
exercise of this Warrant will, upon issuance in accordance with the terms of this Warrant and payment of the Exercise Price therefor, be duly authorized, validly issued, fully paid and nonassessable and free from all preemptive rights of any
stockholder and free of all taxes, liens and charges with respect to the issue thereof. The Company covenants and agrees that, during the Exercise Period, the Company will at all times have authorized and reserved, for the purpose of issuance upon
exercise of this Warrant, a sufficient number of shares of authorized but unissued shares of Common Stock, free from all preemptive rights therein, as shall be required to provide for the exercise of this Warrant. The Warrant Shares are subject to
the terms, rights and provisions set forth in the Company’s articles of incorporation, as amended and/or restated from time to time. 
 5.
FRACTIONAL SHARES. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. With respect to any fraction of a share called for upon any exercise hereof, the Company shall pay to
Holder an amount in cash equal to such fraction multiplied by the weighted average closing price of the Common Stock of the Company for the five days prior to the day of exercise. 
  

 2 

 6. TRANSFER, ASSIGNMENT OR LOSS OF WARRANT. This Warrant may be assigned by Holder to
another person or entity in accordance with the transfer provisions hereof; provided that such assignment shall comply with the provisions of Section 3.1, of the Securities Purchase Agreement and Section 10 of this Warrant.
Upon satisfaction of such terms and conditions, and upon surrender of this Warrant to the Company accompanied by a duly executed assignment form, the Company shall, without charge, execute and deliver a new Warrant in the name of the assignee named
in such instrument of assignment and this Warrant shall promptly be terminated and canceled. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and (in the case of loss, theft or
destruction) the delivery by the Holder to the Company of a reasonably satisfactory affidavit of loss and indemnity (but without any requirement to provide security or post a bond) by Holder, and upon surrender and cancellation of this Warrant, if
mutilated, the Company will execute and deliver a new Warrant of like tenor and date. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether or not this Warrant is lost,
stolen, destroyed, or mutilated, and shall be at any time enforceable by anyone. 
 7. RIGHTS OF THE HOLDER. Holder shall not, by virtue of
this Warrant, be entitled to any of the rights of a stockholder in the Company, either at law or equity, and the rights of Holder are limited to those expressed in this Warrant, provided that Holder may be entitled to other rights as set forth in
other agreements and/or by virtue of being a stockholder in the Company. 
 8. ADJUSTMENT PROVISION. 
 8.1 The number of Warrant Shares issuable hereunder shall be proportionately adjusted upon the occurrence of any Adjustment Event (as hereinafter
defined) such that Holder hereof shall have the right to receive upon the basis and upon the terms and conditions specified in this Warrant and in lieu of the Warrant Shares immediately theretofore purchasable and receivable upon the exercise of
this Warrant, such securities, money or other property as would have been issued or delivered to Holder if Holder had exercised this Warrant and had received such Warrant Shares immediately prior to such Adjustment Event. Upon any adjustment of the
Warrant Shares pursuant to the preceding sentence, the Exercise Price shall be adjusted such that the new Exercise Price is equal to the result obtained by dividing (a) the product of (i) the number of Warrant Shares or other securities
issuable under this Warrant immediately prior to such adjustment, and (ii) the Exercise Price in effect immediately prior to such adjustment, by (b) the number of Warrant Shares or other securities issuable under this Warrant immediately
after such adjustment. As used herein “Adjustment Event” shall mean (a) any reclassification, capital reorganization, recapitalization, stock dividend, stock split or other capital reorganization or change of securities
of the class or series issuable upon the exercise of this Warrant, (b) any consolidation or merger of the Company with or into another corporation or other entity (other than a merger with a subsidiary in which merger the Company is the
continuing corporation and which does not result in any reclassification, capital reorganization or other change of securities of the class or series issuable upon exercise of this Warrant), (c) any sale, lease or conveyance to another person
or entity of all or substantially all the assets of the Company, or (d) an adjustment pursuant to Section 8.2 below. If any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the
Company with or into another corporation, or the sale of all or substantially all of its assets to another corporation shall be 
  

 3 

 effected in such a way that holders of Common Stock shall be entitled to receive stock, securities, cash or other
property with respect to or in exchange for Common Stock, then, as a condition of such reorganization, reclassification, consolidation, merger or sale, lawful and adequate provision shall be made whereby Holder shall have the right to acquire and
receive, upon exercise of this Warrant, such shares of stock, securities, cash or other property issuable or payable (as part of the reorganization, reclassification, consolidation, merger or sale) with respect to or in exchange for such number of
outstanding shares of the Common Stock as would have been received upon exercise of this Warrant at the Exercise Price then in effect. The Company will not effect any such consolidation, merger or sale, unless prior to the consummation thereof the
successor corporation (if other than the Company) resulting from such consolidation or merger or the corporation purchasing such assets shall assume by written instrument mailed or delivered to Holder at the last address of Holder appearing on the
books of the Company, the obligation to deliver to Holder such shares of stock, securities or assets as, in accordance with the foregoing provisions, Holder may be entitled to purchase. If a purchase, tender or exchange offer is made to and accepted
by the holders of more than 50% of the outstanding shares of Common Stock of the Company, the Company shall not effect any consolidation, merger or sale with the person having made such offer or with any Affiliate of such person, unless prior to the
consummation of such consolidation, merger or sale Holder shall have been given a reasonable opportunity to then elect to receive upon the exercise of this Warrant either the stock, securities or assets then issuable with respect to the Common Stock
or the stock, securities or assets, or the equivalent, issued to previous holders of the Common Stock in accordance with such offer. 
 8.2 Until the earlier of the Expiration Date or the date this Warrant is transferred, in whole or in part, by the original Holder hereof, the Exercise Price of this Warrant shall be subject to adjustment as follows: 
 (a) Pursuant to the terms of the Support Agreement dated as of the date hereof, between the Company and Holder, the Company is obligated to deliver
quarterly to the Holder a “Revenue Report” setting forth the “Investor-Related Revenue” (such Investor-Related Revenue, including any adjustment thereto pursuant to the terms of the Support Agreement, is referred to herein as the
“Holder Related Revenue”). The obligation to deliver such Revenue Report reporting the Investor-Related Revenue and all related dispute provisions relating thereto shall be deemed to be set forth herein. 
 (b) Upon the delivery to Holder of the Revenue Report, the Exercise Price shall be adjusted as follows: 
  

							
	 	  	AEP	  	=	  	EP — ((HRR/WS) * 2)
				
	Where:	  	EP	  	=	  	the then-current Exercise Price
		  	AEP	  	=	  	the adjusted Exercise Price
		  	HRR	  	=	  	Holder-Related Revenue for the period covered by the Revenue Report
		  	WS	  	=	  	the number of Warrant Shares issuable upon exercise of the Warrant immediately prior to such adjustment

  

 4 

 For example, if certified Holder-Related Revenue for the first fiscal quarter following the Issue Date
equals $500,000, then the Exercise Price hereunder would be adjusted as follows: 
  

					
	AEP	  	=	  	$12.50 — (($500,000/1,000,000) * 2)
		  	=	  	$12.50 - ($0.50 * 2)
		  	=	  	$12.50 - $1.00
		  	=	  	$11.50

 If certified Holder-Related Revenue for a subsequent fiscal quarter equals $750,000, then the
Exercise Price hereunder would be further adjusted as follows: 
  

					
	AEP	  	=	  	$11.50 — (($750,000/1,000,000) * 2)
		  	=	  	$11.50 - ($0.75 * 2)
		  	=	  	$11.50 - $1.50
		  	=	  	$10.00

 (c) Anything in this Section 8.2 to the contrary notwithstanding, (i) in
no event may the Exercise Price be adjusted pursuant to this Section 8.2 to less than $10.00 per Warrant Share (such number subject to adjustment pursuant to Section 8.1 above to the same extent as the Exercise Price) and if,
at any time the Exercise Price of this Warrant is equal to or less than $10.00 per Warrant Share (such number subject to adjustment pursuant to Section 8.1 above to the same extent as the Exercise Price), then no further adjustments
shall be made pursuant to this Section 8.2, and (ii) any adjustments pursuant to this Section 8.2 shall affect the Exercise Price only, and not the number of Warrant Shares issuable upon exercise of this Warrant.

 8.3 The foregoing provisions of this Section shall similarly apply to successive Adjustment Events. These provisions are not meant
to broaden or lessen any rights Holder has with respect to the underlying securities available for purchase pursuant to the terms of this Warrant. 
 9.
NOTICE TO HOLDERS. Subject to the notice provisions of Section 2 hereof, so long as this Warrant shall be outstanding: (a) if the Company shall pay any dividend or make any distribution upon its Common Stock; (b) if
the Company shall offer to the holders of its Common Stock for subscription or purchase by them any share of any class or any other rights; or (c) if any capital reorganization of the Company (including, without limitation, any
recapitalization, stock dividend, stock split or other capital reorganization), reclassification of the capital stock of the Company, consolidation or merger of the Company with or into another corporation or other entity, sale, lease or transfer of
all or substantially all of the property and assets of the Company to another person or entity, or voluntary or involuntary dissolution, liquidation or winding up of the Company shall be effected, then in any such case, the Company shall cause to be
mailed by certified mail to Holder, at least ten (10) days prior to the date specified in (A) and (B) below, as the case may be, a notice containing a brief description of the proposed action and stating the date on which (A) a
record is to be taken for the purpose of such dividend, distribution or rights, or (B) such reclassification, reorganization, consolidation, merger, conveyance, lease, dissolution, liquidation or winding up is to take place and the date, if any
is to be fixed, as of which the holders of Common Stock or other securities shall receive cash or other property 
  

 5 

 deliverable upon such reclassification, reorganization, consolidation, merger, conveyance, dissolution, liquidation or
winding up. Upon any adjustment of this Warrant as provided herein, then and in each such case the Company shall give prompt written notice thereof, by first class mail, postage prepaid, addressed to Holder of this Warrant at its address registered
on the books of the Company, which notice shall state (i) the increase or decrease, if any, in the Exercise Price resulting from such adjustment, and (ii) the increase or decrease, if any, in the number of Warrant Shares purchasable at
such price upon the exercise of this Warrant, and (iii) any change in the type of security issuable upon exercise hereof setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.

 10. TRANSFER TO COMPLY WITH THE SECURITIES ACT OF 1933. Holder acknowledges that this Warrant and the Warrant Shares have not been
registered under the Securities Act, and therefore agrees not to sell, pledge, distribute, offer for sale, transfer or otherwise dispose of this Warrant or any Warrant Shares issued upon its exercise in the absence of (a) an effective
registration statement under the Securities Act as to this Warrant or such Warrant Shares and registration or qualification of this Warrant or such Warrant Shares under any applicable Blue Sky or state securities law then in effect, or (b) an
exemption from any such registration and qualification (including the delivery of investment representation letters and legal opinions reasonable satisfactory to the Company, if such are requested by the Company). Each certificate or other
instrument for Warrant Shares issued upon the exercise of this Warrant shall bear a legend substantially to the foregoing effect. 
 11. NO
IMPAIRMENT. The Company will not, by amendment of its certificate of incorporation or bylaws or through reorganization, consolidation, merger, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the holder
of this Warrant against impairment. 
 12. MAILING OF NOTICES, ETC. All notices and other communications from the Company to Holder shall be
mailed by first-class certified or registered mail, postage prepaid, to the address furnished to the Company in writing by Holder. All notices and other communications from Holder or in connection herewith to the Company shall be mailed by
first-class certified or registered mail, postage prepaid, to the Company at its principal office set forth on the signature page hereof. If the Company should at any time change the location of its principal office to a place other than as set
forth in the initial paragraph hereof, it shall give written notice to Holder and thereafter all references in this Warrant to the location of its principal office at the particular time shall be as so specified in such notice. 
 13. CHANGE OR WAIVER. Any term of this Warrant may be changed or waived only by an instrument in writing signed by the Company and Holder. 
 14. HEADINGS. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of this
Warrant. 
  

 6 

 15. GOVERNING LAW. This Warrant will be governed by and construed in accordance with the laws of the State
of Nevada, without giving effect to the conflicts of laws principles of that or any other state. 
 [Signatures on following page]

  

 7 

 IN WITNESS WHEREOF, this Common Stock Purchase Warrant is executed and dated as of the Issue Date
set forth above. 
  

			
	 QUEPASA CORPORATION
 7550 E. Redfield
Road, Suite A
 Scottsdale, AZ 85260
 Fax: (480)
951-0221
 Attn: Robert B. Stearns

		
	By:	 	 /s/ Robert B. Stearns

	Name:	 	Robert B. Stearns
	Title:	 	Chairman and Chief Executive Officer

 PURCHASE FORM 
 Dated:
                    , 200    . 
 The undersigned, pursuant to the provisions set forth in the attached Warrant No. MATT No. 1, hereby irrevocably elects to purchase
             shares of the Common Stock covered by such Warrant for the Exercise Price per share as calculated pursuant to the terms of such Warrant and herewith makes payment of
$                                     
              representing the full purchase price for such shares at the Exercise Price per share provided for in such Warrant. 
 INSTRUCTIONS FOR REGISTRATION OF STOCK 
  

									
		 		 	Name	 	  
	 	
		 		 		 	(Please typewrite or print in block letters)	 	
					
		 		 	Address:	 	  
	 	
		 		 		 	  
	 	
					
		 		 		 	  
	 	
		 		 		 	Signature	 	

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]